Grandfield & Dodd, LLC Incyte Corp Transaction History
Grandfield & Dodd, LLC
- $1.58 Billion
- Q3 2024
A detailed history of Grandfield & Dodd, LLC transactions in Incyte Corp stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 19,525 shares of INCY stock, worth $1.39 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
19,525
Previous 18,915
3.22%
Holding current value
$1.39 Million
Previous $1.15 Million
12.57%
% of portfolio
0.08%
Previous 0.08%
Shares
29 transactions
Others Institutions Holding INCY
# of Institutions
642Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.18 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.52 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.45 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.09 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$750 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...